Viewing Study NCT04746287



Ignite Creation Date: 2024-05-06 @ 3:45 PM
Last Modification Date: 2024-10-26 @ 1:56 PM
Study NCT ID: NCT04746287
Status: COMPLETED
Last Update Posted: 2022-05-04
First Post: 2021-01-15

Brief Title: Evaluation of the Safety and Tolerability of CKD-510 in Healthy Subjects
Sponsor: Chong Kun Dang Pharmaceutical
Organization: Chong Kun Dang Pharmaceutical

Study Overview

Official Title: First-in-Human Randomized Double-blind Placebo-controlled Study to Evaluate Safety Tolerability Pharmacokinetics Pharmacodynamics and Food Effects of CKD-510 in Single Ascending Dose and Multiple Ascending Dose in Healthy Subjects
Status: COMPLETED
Status Verified Date: 2022-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This is a first-in-human study of CKD-510 in single-ascending dose and multiple-ascending dose in healthy subjects This trial is a randomized double-blind placebo-controlled study to evaluate the safety tolerability pharmacokinetics pharmacodynamics of food effects of CKD-510
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None